Market Introduction
Non-invasive or non-surgical aesthetic treatment refers to the aesthetic procedures that does not require any kind of surgical incision. Sometimes, minimally invasive surgeries are also considered as non-surgical procedures. Some of the commonly conducted non-invasive aesthetic treatment includes botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion amongst other.
Market Overview and Dynamics
The South and Central America non-invasive aesthetic treatment market is expected to reach US$ 542.91 million by 2028 from US$ 274.29 million in 2021; it is estimated to grow at a CAGR of 10.2% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as rising number of non-invasive aesthetic/cosmetic procedures performed every year and surging awareness about cosmetic procedures among consumers. However, clinical risks and complications associated with medical aesthetic procedures is hindering the market growth.
Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their noninvasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Therefore, the advantages of minimally invasive procedures over conventional surgery—such as faster recovery, reduced pain, and shortened hospital stays, and greater efficiency rate—contribute to the non-invasive aesthetic treatment market growth. According to a recent report by the International Society of Aesthetic Plastic Surgery (2018), the total number of non-surgical procedures performed globally was above 12 million in 2018. The advancements in nonsurgical technologies and unveiling of new surgery options have made aesthetics accessible to people. For example, the advantages of laser procedures have attracted younger people to improve their skin conditions, modify body parts, and correct their physical posture. Therefore, rising acceptance of non-invasive aesthetic/cosmetic procedures is driving the growth of the South and Central America non-invasive aesthetic treatment market. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people, which is also boosting the market growth.
South and Central America is highly affected due to the COVID-19 outbreak pandemic. The outbreak has severely impacted the flow of medical services and medical tourism in the region. The Division of Plastic Surgery in Latin America suspended nonessential operations and outpatient consultations, achieving new guidelines (ANG) of national and international associations. Moreover, countries in this region are significantly dependent on the US and European countries for medical resources, which are under lockdown. Thus, the South and Central America non-invasive aesthetic treatment market in the region has experienced a significant slowdown and is expected to witness the same in the following two to three years.
Key Market Segments
The South and Central America non-invasive aesthetic treatment market, based on procedure, is segmented into injectables, skin rejuvenation, and others. The injectables segment held the largest share of the market in 2020, and the market for the same segment is expected to grow at the fastest rate during the forecast period.
The South and Central America non-invasive aesthetic treatment market, by end user, is segmented into hospitals, clinics and medical spas, and others. The hospitals segment held the largest share of the market in 2020. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the South and Central America non-invasive aesthetic treatment market are the American Society for Aesthetic Plastic Surgery (ASAPS), Centers for Disease Control and Prevention (CDC) and National Health Service (NHS).
Reasons to buy the report
SOUTH AND CENTRAL AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET SEGMENTATION
By Procedure
By End User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 274.29 Million |
| Market Size by 2028 | US$ 542.91 Million |
| CAGR (2021 - 2028) | 10.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Procedure
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Non-Invasive Aesthetic Treatment Market is valued at US$ 274.29 Million in 2021, it is projected to reach US$ 542.91 Million by 2028.
As per our report South and Central America Non-Invasive Aesthetic Treatment Market, the market size is valued at US$ 274.29 Million in 2021, projecting it to reach US$ 542.91 Million by 2028. This translates to a CAGR of approximately 10.2% during the forecast period.
The South and Central America Non-Invasive Aesthetic Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Non-Invasive Aesthetic Treatment Market report:
The South and Central America Non-Invasive Aesthetic Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Non-Invasive Aesthetic Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Non-Invasive Aesthetic Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)